Metabolomics of oncogene-specific metabolic reprogramming during breast cancer

被引：0
作者：
Chen Dai
Jennifer Arceo
James Arnold
Arun Sreekumar
Norman J. Dovichi
Jun Li
Laurie E. Littlepage
机构：
[1] University of Notre Dame,Department of Chemistry and Biochemistry
[2] University of Notre Dame,Harper Cancer Research Institute
[3] Baylor College of Medicine,Department of Biochemistry and Molecular Biology
[4] University of Notre Dame,Department of Applied and Computational Mathematics and Statistics
来源：
Cancer & Metabolism | / 6卷
关键词：
Breast cancer; Oncogene; Transgenic mouse model; Metabolic reprogramming; Metabolomics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 175 条
  • [1] Vander Heiden MG(2009)Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 324 1029-1033
  • [2] Cantley LC(2011)Regulation of cancer cell metabolism Nat Rev Cancer 11 85-95
  • [3] Thompson CB(2012)Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate Cancer Cell 21 297-308
  • [4] Cairns RA(2013)Oncometabolites: linking altered metabolism with cancer J Clin Invest 123 3652-3658
  • [5] Harris IS(2009)Metabolic enzymes as oncogenes or tumor suppressors N Engl J Med 360 813-815
  • [6] Mak TW(2012)IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics Nature 488 656-659
  • [7] Ward PS(2009)Cancer-associated IDH1 mutations produce 2-hydroxyglutarate Nature 462 739-744
  • [8] Thompson CB(2010)IDH1 mutations in gliomas: when an enzyme loses its grip Cancer Cell 17 7-9
  • [9] Yang M(2014)L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer Cancer Discov 4 1290-1298
  • [10] Soga T(2014)MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis J Clin Invest 124 398-412
12345678910